Propensity score-matched analysis of comprehensive local therapy for oligometastatic non-small cell lung cancer that did not progress after front-line chemotherapy
Time Machine $199 This is one of our most popular drips for people feeling well who want to stay that way
doi: 10.1002/pmic.201800311 24 ZouYHenryWSRicqELGrahamETPhadnisVVMaretichPet al
This article reports what has been documented, not what should be done
Andreeff M , R-Y W, Davis E, Jacamo R, Ruvolo P, McQueen T, Huang X, Battula VL, Chen Y, Majumdar S, Benito JM, Zeng Z, Benton C, Carter B, Mu H, Ma W, Ruvolo V, Hodgson L, Konoplev S, Pan R, Somanchi A, Strunck D, Zhang Q, Kornblau SM, Kantarjian H, Marcucci G, Garzon R, Zuber J, Lowe S, Croce C, Konopleva M